Computational Analysis Identifies Novel Biomarkers for High-Risk Bladder Cancer Patients

In the case of bladder cancer, carcinoma in situ (CIS) is known to have poor diagnosis. However, there are not enough studies that examine the biomarkers relevant to CIS development. Omics experiments generate data with tens of thousands of descriptive variables, e.g., gene expression levels. Often,...

Descripción completa

Detalles Bibliográficos
Autores principales: Piliszek, Radosław, Brożyna, Anna A., Rudnicki, Witold R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266725/
https://www.ncbi.nlm.nih.gov/pubmed/35806060
http://dx.doi.org/10.3390/ijms23137057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266725/
https://www.ncbi.nlm.nih.gov/pubmed/35806060
http://dx.doi.org/10.3390/ijms23137057

Ejemplares similares